Loading live market data…

Ultragenyx Pharmaceutical Inc.

NASDAQ:RARE

$32.03 USD

-$1.19 (-3.58%)

Volume
0
Average Volume
2.2M
Market Capitalization
$3.15B
P/E Ratio
-5.24
Dividend Yield
0.00%
Price Target
$43.00
Year High
$39.89
Year Low
$18.29
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.02

RARE Estimated and Actual Revenue by Quarter

RARE Estimated and Actual EPS by Quarter

RARE Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 5 -329.73M -267.02M -303.78M -338.11M -273.81M -311.5M
2027-09-30 5 -254.26M -205.9M -234.24M -260.72M -211.13M -240.2M
2027-06-30 5 -235.45M -190.67M -216.92M -241.43M -195.52M -222.43M
2027-03-31 5 -195.78M -158.55M -180.37M -200.76M -162.58M -184.96M
2026-12-31 5 -236.85M -191.8M -218.21M -242.87M -196.68M -223.75M
2026-09-30 10 -170.7M -160.49M -167M -175.04M -164.57M -171.25M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 5 53.69M 70.79M 63.71M 188.01M 232.16M 213.89M
2027-09-30 5 -931.4K -706.43K -838.3K 144.97M 179.02M 164.93M
2027-06-30 5 -25.34M -19.22M -22.8M 134.25M 165.78M 152.73M
2027-03-31 5 -79.04M -59.95M -71.14M 111.63M 137.85M 127M
2026-12-31 5 -51.81M -39.29M -46.63M 135.05M 166.76M 153.64M
2026-09-30 10 -149.4M 27.94M -103.24M 113M 120.19M 117.59M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 5 293.98M 363.02M 334.45M 1 0.5337 0.70367 0.63333
2027-09-30 5 226.69M 279.93M 257.89M 1 -0.00925847 -0.00702214 -0.008333
2027-06-30 5 209.92M 259.22M 238.82M 1 -0.25184 -0.19101 -0.22667
2027-03-31 5 174.56M 215.55M 198.59M 1 -0.78568 -0.5959 -0.70714
2026-12-31 5 211.17M 260.76M 240.24M 1 -0.51499 -0.3906 -0.46351
2026-09-30 10 176.69M 187.94M 183.87M 5 -1.48504 0.27769 -1.02625